Nutex Health (NASDAQ:NUTX) Price Target Raised to $325.00

Nutex Health (NASDAQ:NUTX) had its target price increased by B. Riley Financial from $290.00 to $325.00 in a research report released on Friday, Marketbeat.com reports. The firm currently has a buy rating on the stock.

NUTX has been the subject of several other research reports. Zacks Research upgraded shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 24th. Lake Street Capital restated a “buy” rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Wall Street Zen lowered shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Monday, July 20th. Finally, Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, Nutex Health currently has an average rating of “Buy” and a consensus target price of $317.50.

Nutex Health Price Performance

Shares of NUTX stock opened at $193.24 on Friday. The stock’s 50-day moving average is $175.59 and its 200 day moving average is $137.01. Nutex Health has a 1-year low of $80.53 and a 1-year high of $204.00. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. The company has a market cap of $1.32 billion, a P/E ratio of 7.59 and a beta of 0.28.

Nutex Health (NASDAQ:NUTX) last announced its earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. The business had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%.

Institutional Investors Weigh In On Nutex Health

Several institutional investors and hedge funds have recently made changes to their positions in NUTX. Kilter Group LLC purchased a new stake in shares of Nutex Health during the second quarter valued at $27,000. Islay Capital Management LLC purchased a new position in Nutex Health in the 4th quarter worth $34,000. Allworth Financial LP acquired a new stake in Nutex Health during the 2nd quarter worth about $35,000. BNP Paribas Financial Markets lifted its position in Nutex Health by 966.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after acquiring an additional 290 shares during the period. Finally, Royal Bank of Canada lifted its position in Nutex Health by 752.4% during the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after acquiring an additional 316 shares during the period. 5.32% of the stock is currently owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.